Heat Biologics sets IPO range

Cancer company Heat Biologics Inc. (Chapel Hill, N.C.) amended its IPO and now plans to sell 1.7 million shares at $10-$12. At the $11 midpoint, Heat Biologics would raise $18.2 million and be valued at $57.6 million. Earlier this month, Heat proposed to raise up to $20 million in the IPO. The company also added Cantor Fitzgerald as an underwriter. Aegis Capital is also an underwriter. ...